Estella Lin
About Estella Lin
Estella Lin is a Clinical Trial Manager at Bristol Myers Squibb, overseeing regional clinical operations in Japan, Korea, and Taiwan.
Current Position at Bristol Myers Squibb
Estella Lin is currently serving as the Clinical Trial Manager, Regional Clinical Operations for Japan, Korea, and Taiwan at Bristol Myers Squibb. Based in Taipei City, Taiwan, Lin is responsible for overseeing clinical trial activities within this significant regional scope. Her role involves ensuring compliance, managing timelines, and coordinating with various stakeholders to ensure the smooth execution of clinical trials.
Previous Roles and Experience
Before her current position, Estella Lin held various key roles in the clinical research field. She worked as a Clinical Project Leader at Sanofi, outsourced by Labcorp/IQVIA, for two years. Lin has also been part of IQVIA, where she served as Clinical Research Associate II and Clinical Research Associate. Additionally, she began her clinical research career with A2 Healthcare as a Clinical Research Associate and Clinical Trial Assistant. These roles were all based in Taipei City, Taiwan, providing her with extensive local experience.
Educational Background
Estella Lin pursued her higher education at National Taiwan University, where she earned a Master's Degree in Environmental Health. She furthered her studies at China Medical University. Her academic background provided a solid foundation for her subsequent career in clinical research and operations.
Laboratory and Training Expertise
During her academic and professional career, Estella Lin has managed two BSL-2 laboratories and played a significant role in organizing institutional meeting symposiums. She has also collaborated with diverse teams and trained undergraduate students and foreign lab technicians, showcasing her leadership and mentoring abilities.
Recognition and Skills
Estella Lin's work has been recognized by multiple honors and awards from both Sanofi and IQVIA for her exceptional performance. She possesses notable expertise in managing FDA inspections, inspections of human cellular and tissue-based products, and sponsor/EC audits. Lin's clinical research experience spans multiple therapeutic areas, including oncology, T2DM, airway diseases, kidney diseases, autoimmune diseases, and rare diseases.